Jump to content

Talk:Eric Verdin

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
(Redirected from Talk:Eric M. Verdin)

Citing different sources

[edit]

Hello, I would like to cite more secondary/tertiary sources for this article.

1. Source for his educational background: https://www.bizjournals.com/sanfrancisco/news/2018/07/05/ceo-eric-verdin-buck-institute-pharma.html
2. Source for his affiliation with UCSF: https://www.northbaybusinessjournal.com/northbay/marincounty/6482105-181/buck-institute-aging-research-biotech-novato
3. Source for HDACs: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970420/
4. Source for being highly cited: https://scholar.google.com/citations?user=SKFD2LcAAAAJ&hl=en. We will need to actually change the sentence into: "He is a highly cited scientist with h-index of 103 and has been recognized for his research with a Glenn Award for Research in Biological Mechanisms of Aging and a senior scholarship from the Ellison Medical Foundation."
5. Source for the number of patents: https://patents.justia.com/inventor/eric-verdin
6. Source for number of papers: https://scholar.google.com/citations?user=SKFD2LcAAAAJ&hl=en. Can we change the sentence into: "He has published more than 300 scientific papers and currently holds 20 patents."?

Also, I would like to add a sentence about how Dr. Verdin was involved with the launch of a biotechnology company called Napa Therapeutics in August 2018: "Napa Therapeutics, a biotechnology company that focuses on developing drugs against aging-related targets, was built on the NAD metabolism research from Verdin's lab." Here is the source: https://www.biospace.com/article/buck-institute-insilico-med-and-juvenescence-found-napa-therapeutics-to-focus-on-age-related-diseases/.

Thank you! Irenepark89 (talk) 23:38, 14 January 2019 (UTC)[reply]

Reply 15-JAN-2019

[edit]

Below you will see where proposals from your request have been quoted with reviewer decisions and feedback inserted underneath, either accepting, declining or otherwise commenting upon your proposal(s). Please read the enclosed notes within the proposal review section below for information on each request.  Spintendo  12:02, 15 January 2019 (UTC)[reply]

Proposal review 15-JAN-2019

Source for his educational background: https://www.bizjournals.com/sanfrancisco/news/2018/07/05/ceo-eric-verdin-buck-institute-pharma.html
 Unable to implement.[note 1]


Source for his affiliation with UCSF: https://www.northbaybusinessjournal.com/northbay/marincounty/6482105-181/buck-institute-aging-research-biotech-novato
 Approved.[note 2]


Source for HDACs: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970420/
no Declined.[note 3]


Source for being highly cited: https://scholar.google.com/citations?user=SKFD2LcAAAAJ&hl=en We will need to actually change the sentence into: "He is a highly cited scientist with h-index of 103 and has been recognized for his research with a Glenn Award for Research in Biological Mechanisms of Aging and a senior scholarship from the Ellison Medical Foundation."
no Declined.[note 4]


Source for the number of patents: https://patents.justia.com/inventor/eric-verdin
 Approved.[note 5]


Source for number of papers: https://scholar.google.com/citations?user=SKFD2LcAAAAJ&hl=en Can we change the sentence into: "He has published more than 300 scientific papers and currently holds 20 patents."?
no Declined.[note 6]


Napa Therapeutics, a biotechnology company that focuses on developing drugs against aging-related targets, was built on the NAD metabolism research from Verdin's lab.
no Declined.[note 7]


___________

  1. ^ This reference could not be added because the source is behind a paywall. Please provide a quote of the content by placing the information under the |quote= parameter of the reference template.
  2. ^ The source for this claim ideally would have come from UCSF, as they are the final source on whether the subject has an association with their institution. Nevertheless, the reference was added.
  3. ^ This part of the edit request proposal was declined because the provided source does not state which lab it was who first cloned this family of enzymes. The source provided by the proposed source states that the first histone deacetylase, HDAC1, was isolated and cloned in 1996.[1] The subject's name is not part of the authors listed in that source.
  4. ^ This part of the edit request proposal was declined because it uses the subjective word highly. The use of that word in the article has been omitted. This word in relation to being cited is acceptable.
  5. ^ According to the provided source, the subject has filed for patents to protect twenty (20) inventions. Of those 20, five (5) have been granted by the United States Patent and Trademark Office (USPTO) while fifteen (15) applications are still pending. The article has been updated to reflect this count with qualifications as provided by the source.
  6. ^ This part of the edit request proposal was declined because the number of patents granted is not verified by the provided source.
  7. ^ This part of the edit request proposal was declined because it is unclear what is meant by the words "was built on."

References

  1. ^ Schreiber, Stuart L.; Hassig, Christian A.; Taunton, Jack (19 April 1996). "A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p". Science. 272 (5260): 3. doi:10.1126/science.272.5260.408. ISSN 0036-8075.

Request edit

[edit]

Thank you! I would like to propose the following references and/or addition of new sentences to address the concerns.

1. For "A native of Belgium, Verdin received his Doctorate of Medicine (MD) from the University of Liege and additional clinical and research training at Harvard Medical School. He has held faculty positions at the University of Brussels, the National Institutes of Health (NIH), and the Picower Institute for Medical Research." https://www.northbaybusinessjournal.com/northbay/marincounty/6354003-181/buck-institute-hires-new-ceo

2. "He has an h-index of 103 and has been recognized for his research with a Glenn Award for Research in Biological Mechanisms of Aging in 2010 and a senior scholarship from the Ellison Medical Foundation in 2003." https://scholar.google.com/citations?user=SKFD2LcAAAAJ&hl=en&oi=ao, https://www.ellisonfoundation.org/content/role-sirt3-sir2-related-mitochondrial-protein-deacetylase-aging, and https://glennfoundation.org/awards-programs/glenn-awards/

3. "Napa Therapeutics, a biotechnology company that focuses on developing drugs against aging-related targets, is based on the NAD metabolism research from Verdin's lab." https://www.biospace.com/article/buck-institute-insilico-med-and-juvenescence-found-napa-therapeutics-to-focus-on-age-related-diseases/

Irenepark89 (talk) 21:51, 30 January 2019 (UTC)[reply]

Reply 30-JAN-2019

[edit]

Below you will see where proposals from your request have been quoted with reviewer decisions and feedback inserted underneath, either accepting, declining or otherwise commenting upon your proposal(s). Please read the enclosed notes within the proposal review section below for information on each request. Please note that the COI editor's use of the {{connected contributor}} template is incomplete, as the template has not been filled out.  Spintendo  22:44, 30 January 2019 (UTC)[reply]

Proposal review 30-JAN-2019

A native of Belgium, Verdin received his Doctorate of Medicine (MD) from the University of Liege and additional clinical and research training at Harvard Medical School. He has held faculty positions at the University of Brussels, the National Institutes of Health (NIH), and the Picower Institute for Medical Research.
Clarification needed.[note 1]


He has an h-index of 103
 Approved.Cite error: There are <ref> tags on this page without content in them (see the help page).


and has been recognized for his research with a Glenn Award for Research in Biological Mechanisms of Aging in 2010
no Declined.[note 2]


and a senior scholarship from the Ellison Medical Foundation in 2003.
no Declined.[note 3]


Napa Therapeutics, a biotechnology company that focuses on developing drugs against aging-related targets, is based on the NAD metabolism research from Verdin's lab.
Clarification needed.[note 4]


___________

  1. ^ Please provide sourcing from the University of Liege. Regarding the "additional clinical research training" at Harvard please specify what this included, and provide sourcing from Harvard. Please provide references from NIH and the PIMR for those claims.
  2. ^ This part of the edit request proposal was declined because the award is not notable in Wikipedia. A subject is considered notable if it has its own Wikipedia page.
  3. ^ This part of the edit request proposal was declined because the subject's financial sources are not notable.
  4. ^ This part of the edit request proposal requires clarification because it is not known what is meant by the phrase "a company....is based on the NAD metabolism research from Verdin's lab". Please delineate how and in what way a company and its day to day operations would be based on clinical lab research.

removing a warning box at the top of the page

[edit]

Hello, I am the Communications Manager at the Buck Institute for Research on Aging and would like to have the warning removed from the top of our CEO's page. It says: "This article may have been created or edited for undisclosed payments..." I have posted a disclosure statement that i work for the organization for which i am trying to edit the page and the CEO's page. How can i have that warning box removed? There are edits the CEO would like to his page - updates to his bio.

Thank you! Chloe — Preceding unsigned comment added by Chloecaviness (talkcontribs) 18:06, 17 May 2019 (UTC)[reply]

Hi, I'll invite Doc James to this discussion; he made the edit at Special:Diff/866651414 and will likely be able to help here. ~ ToBeFree (talk) 18:15, 17 May 2019 (UTC)[reply]
You were not the paid editor that edited this page undisclosed though. Additionally you should only post suggestions here and not edit the article directly. Doc James (talk · contribs · email) 10:05, 19 May 2019 (UTC)[reply]

@Doc James: - how can i rectify this situation and get that warning box removed? What content do you find questionable and can i do anything to ease your concerns? Chloecaviness (talk) 18:30, 20 May 2019 (UTC)[reply]

@Doc James: Hi Doc James, Can you please let me know how i can rectify this issue so you feel comfortable removing that warning box? What content do you find questionable? Chloecaviness 18:05, 22 July 2019 (UTC)[reply]